Cures Act expanded enrollment eligibility for Medicare Advantage to include people with end-stage kidney disease. Sometimes ...

Enrollment in company’s first-of-its-kind placebo-controlled Phase 2 study to evaluate the efficacy of crofelemer for ...

Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

Cuts to federal research funding may delay a potential hepatitis B cure, as trials led by UCSF progress. Asian Americans ...

The drug promotes lipophagy and hepatic fatty acid beta-oxidation to reduce liver fat, inflammation, and liver fibrosis.

There was no association observed between lower income and increased fibrosis among New York City residents with metabolic dysfunction-associated steatohepatitis (MASH).

Ashwagandha supplements can boost your physical and mental health. But they also come with dangerous side effects, the most ...

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of the general population and is ...

Secondary forms of metabolic dysfunction-associated steatotic liver disease (MASLD) have different pathogeneses, ...

Follow-up reached a median 5.5 years overall. Adverse liver outcomes in question counted cirrhosis, decompensation, ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...